CAS and Molecule.one Announce a Strategic Collaboration to Accelerate Drug Discovery
Beyond their complementary capabilities, the organizations’ collaboration is fueled by their shared goal to empower scientists and accelerate breakthroughs.
- Beyond their complementary capabilities, the organizations’ collaboration is fueled by their shared goal to empower scientists and accelerate breakthroughs.
- M1 RetroScore powered by CAS is the first commercially available synthetic accessibility scoring tool trained on CAS content.
- Molecule.one and CAS are also collaborating to enhance the world-class retrosynthesis capabilities already available in CAS SciFindern.
- “Chemical reactions and retrosynthesis capabilities from CAS are unparalleled,” says Tim Wahlberg, Chief Product Officer for CAS.